Monitoring people with MEN1 and related hormone gland tumors
Part of Cancer clinical trials.
This study follows people who have Multiple Endocrine Neoplasia type 1 (MEN1), a genetic condition that can cause tumors in hormone glands. It aims to monitor symptoms and lesions over time to better understand how the condition progresses and how to manage it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You agree to take part (and if you’re under 18, your parent/guardian agrees too)
- You have symptoms from MEN1, meaning at least two affected areas: parathyroid, pancreas, or pituitary
- Or you have a known MEN1-related tumor plus a confirmed MEN1 gene mutation
- Or you have a tumor and a confirmed family history of MEN1
- If you have no symptoms, you still may qualify if you have a confirmed MEN1 gene mutation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with Multiple Endocrine Neoplasia type 1 (MEN1) over time, including those with symptoms, certain isolated hormone gland problems, and people without symptoms who have the MEN1 gene change. It may help doctors learn how MEN1 starts and progresses so care can be better timed and personalized.
This study is testing a new blood test to see if it can help diagnose neuroendocrine tumors in people with MEN1, a genetic condition that increases the risk of these tumors. The test looks for a protein called hPG80 (progastrin) and may help doctors find tumors earlier.
This study looks at blood chemistry (metabolomics) and genetic information in people who have MEN1, especially if they are being evaluated for pancreatic neuroendocrine tumors. It may help doctors better diagnose these tumors by finding patterns in test results.
This study follows children and adults with medullary thyroid cancer (MTC) and/or MEN2 to better understand how the condition progresses over time. It may help doctors plan care in the future by collecting long-term health and lab information, not by giving a new treatment.
This trial is building a database to better understand Multiple Endocrine Neoplasia Type 1 (MEN1). If you have been diagnosed with MEN1, you may be eligible to help researchers learn more about the condition.
This study tracks people with NF1 to watch for when benign nerve tumors turn cancerous. It uses regular MRI scans to catch changes early, which could help guide treatment decisions.
Hear when a new MEN1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.